JNJ – johnson & johnson (US:NASDAQ)

News

J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? [Yahoo! Finance]
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash [Yahoo! Finance]
Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves [Yahoo! Finance]
AstraZeneca News On Cancer And Asthma Raises New Questions For Investors [Yahoo! Finance]
Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com